Application 220360
- Type
- ANDA
- Sponsor
- MANKIND PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LATANOPROST | LATANOPROST | SOLUTION/DROPS;OPHTHALMIC | 0.005% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220360-001 | LATANOPROST | LATANOPROST | 0.005% | SOLUTION/DROPS / OPHTHALMIC | 2025-12-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220360-001 | LATANOPROST | 0.005% | SOLUTION/DROPS / OPHTHALMIC | 2025-12-17 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A220360-001 | LATANOPROST | 0.005% | SOLUTION/DROPS / OPHTHALMIC | 2025-12-17 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A220360-001 | LATANOPROST | 0.005% | SOLUTION/DROPS / OPHTHALMIC | AT | 2025-12-17 | 011fe1cb6892… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220360-001 | LATANOPROST | 0.005% | SOLUTION/DROPS / OPHTHALMIC | 2025-12-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A220360-001 | AT | 1 | 011fe1cb6892… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LATANOPROST | LATANOPROST | NuCare Pharmaceuticals,Inc. | be74d517-7f73-a74c-e053-2a95a90a3819 | 2026-09-04 | Warnings, Adverse reactions | LATANOPROST LATANOPROST |
| Latanoprost | LATANOPROST | Micro Labs Limited | 298fc762-f4d4-47cb-a7a2-b5dc7f965c7f | 2026-01-21 | Warnings, Adverse reactions | Latanoprost LATANOPROST |
| LATANOPROST | LATANOPROST | Rising Pharma Holdings, Inc. | e25b82a9-1b04-4b40-8472-be107a2a6731 | 2026-01-02 | Warnings, Adverse reactions | LATANOPROST LATANOPROST |
| LATANOPROST | LATANOPROST | Somerset Therapeutics, LLC | 5d0b99ad-f05a-44c7-ac61-26b5a533ea8d | 2025-12-22 | Warnings, Adverse reactions | LATANOPROST LATANOPROST |
| XELPROS | LATANOPROST | Sun Pharmaceutical Industries, Inc. | 34ad5cf6-4df0-4104-bddd-4c7631133ded | 2025-12-18 | Warnings, Adverse reactions | LATANOPROST |
| latanoprost | LATANOPROST | GLENMARK PHARMACEUTICALS INC | 821d2ad5-a430-4fd2-8cfd-50b2118b8639 | 2025-12-18 | Warnings, Adverse reactions | latanoprost LATANOPROST |
| Latanoprost | LATANOPROST | Bausch & Lomb Incorporated | 68aaacbe-98c5-450b-9bf4-4809d7ad2ca0 | 2025-10-23 | Warnings, Adverse reactions | Latanoprost LATANOPROST |
| Latanoprost | LATANOPROST | NuCare Pharmaceuticals, Inc. | 3c47a089-2c72-f58c-e063-6294a90a4cce | 2025-08-13 | Warnings, Adverse reactions | Latanoprost LATANOPROST |
| Latanoprost | LATANOPROST | Sagent Pharmaceuticals | 7474dc53-e5e5-44f2-9f56-b2cbacdc0c32 | 2025-06-26 | Warnings, Adverse reactions | Latanoprost LATANOPROST |
| Latanoprost | LATANOPROST | A-S Medication Solutions | 5f1987e0-b0ce-47b2-998b-97453a7db5c3 | 2025-01-09 | Warnings, Adverse reactions | Latanoprost LATANOPROST |
| latanoprost | LATANOPROST | Gland Pharma Limited | 113abcc6-6e5c-4a57-ad6a-d69508ee990e | 2024-11-29 | Warnings, Adverse reactions | latanoprost LATANOPROST |
| Latanoprost | LATANOPROST | Proficient Rx LP | bfd773ed-c461-4732-b1ba-0c240f3fdae0 | 2024-10-01 | Warnings, Adverse reactions | Latanoprost LATANOPROST |
| Latanoprost | LATANOPROST | Aurobindo Pharma Limited | 19cdfef0-b770-4758-8f59-1769e4b6119c | 2024-09-27 | Warnings, Adverse reactions | Latanoprost LATANOPROST |
| Latanoprost | LATANOPROST | Mylan Pharmaceuticals Inc. | 463ecfde-5acb-4983-969d-0c0021bfbf48 | 2024-09-15 | Warnings, Adverse reactions | Latanoprost LATANOPROST |
| Latanoprost | LATANOPROST | A-S Medication Solutions | 8fb5edec-d94a-4aad-b42e-756267a3ae55 | 2024-02-27 | Warnings, Adverse reactions | Latanoprost LATANOPROST |
| XALATAN | LATANOPROST | Viatris Specialty LLC | a98595b3-9f47-48e0-b18d-550a2095f264 | 2023-05-15 | Warnings, Adverse reactions | LATANOPROST |
| Latanoprost | LATANOPROST | Sandoz Inc | 1fba56a6-c8dc-4f34-b05d-efdea75d2fea | 2023-01-31 | Warnings, Adverse reactions | Latanoprost LATANOPROST |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.